跳至主要内容
临床试验/EUCTR2005-005122-31-ES
EUCTR2005-005122-31-ES进行中(未招募)1 期

Evaluation of the effects on heart rate, haemodynamic parameters, safety and tolerability of 5 mg bolus of ivabradine followed by 8-hour infusion at the dose of 5 mg of ivabradine given after a percutaneous coronary intervention following a myocardial infarction with ST segment elevation

Institut de Recherches Internationales (for France)0 个研究点目标入组 75 人开始时间: 2006年3月9日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Male or female patients,
  • - aged between 40 and 80 years (inclusive),
  • - HR > 80 bpm in sinus rythm,
  • - patients who underwent a Percutaneous Coronary Intervention following an acute myocardial infarction with ST segment elevation.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Sick sinus syndrome;
  • - second-degree or third-degree AV block;
  • - trifascicular block and PR > 240 ms;
  • - hypertrophic cardiomyopathy, severe valvular disease, or severe congenital heart disease;
  • - suspected aortic dissection;
  • - known relevant electrolyte disorders.

研究者

发起方
Institut de Recherches Internationales (for France)

相似试验